BioCentury
ARTICLE | Company News

Curis, Elan deal

July 9, 2001 7:00 AM UTC

The companies entered into a binding letter of intent to form and fund a new company to develop hedgehog agonists to treat and prevent neurological disorders. Hedgehog proteins are a class of human pr...